Shopping Cart
- Remove All
- Your shopping cart is currently empty
DOTA Zoledronate represents a novel, advanced compound utilized specifically in bone-targeted radionuclide therapy to diagnose bone metastases.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | Backorder |
Description | DOTA Zoledronate represents a novel, advanced compound utilized specifically in bone-targeted radionuclide therapy to diagnose bone metastases. |
In vitro | DOTA-Zoledronate represents a promising compound for advancing new radionuclide therapy strategies in personalized nuclear oncology. |
Molecular Weight | 701.564 |
Formula | C23H41N7O14P2 |
Cas No. | 1908409-18-6 |
Relative Density. | 1.68 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.